Search

Search Constraints

You searched for: Author/Creator Pfeffer, Marc A.

Search Results

41. International Geographic Variation in Event Rates in Trials of Heart Failure With Preserved and Reduced Ejection Fraction. Issue 1 (6th January 2015)

42. Klotho, fibroblast growth factor‐23, and the renin–angiotensin system — an analysis from the PEACE trial. (18th February 2019)

44. Longitudinal trajectories in renal function before and after heart failure hospitalization among patients with heart failure with preserved ejection fraction in the PARAGON‐HF trial. (15th August 2022)

45. Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease. Issue 5 (4th March 2019)

46. Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF Trial. (22nd November 2021)

47. Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF Trial. (December 2021)

48. N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status. (March 2019)

49. Natriuretic peptide‐based inclusion criteria in heart failure with preserved ejection fraction clinical trials: insights from PARAGON‐HF. (14th February 2022)

50. New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessment. (27th March 2017)